Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 35,378 shares at $161.88 ($5.7M) on 2026-02-26, disclosed to the SEC on 2026-02-27.
Open-market sale of $5.7M AXSM by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |
| AXSM | SELL | 2025-06-10 | $2.8M | — | Filing → |